Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
3.120
-0.300 (-8.77%)
At close: Dec 5, 2025, 4:00 PM EST
3.200
+0.080 (2.56%)
After-hours: Dec 5, 2025, 7:56 PM EST
Tempest Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Tempest Therapeutics stock have an average target of 12.5, with a low estimate of 9.00 and a high estimate of 16. The average target predicts an increase of 300.64% from the current stock price of 3.12.
Analyst Consensus: Hold
* Price targets were last updated on Apr 10, 2025.
Analyst Ratings
The average analyst rating for Tempest Therapeutics stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy → Hold Downgrades $91 → $9 | Buy → Hold | Downgrades | $91 → $9 | +188.46% | Apr 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $16 | Strong Buy → Hold | Downgrades | $16 | +412.82% | Apr 10, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $169 → $91 | Buy | Maintains | $169 → $91 | +2,816.67% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $611 → $208 | Strong Buy | Maintains | $611 → $208 | +6,566.67% | Mar 28, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $104 → $65 | Buy | Maintains | $104 → $65 | +1,983.33% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-13.04
from -19.50
EPS Next Year
-16.34
from -13.04
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -13.42 | -16.82 | |
| Avg | -13.04 | -16.34 | |
| Low | -12.52 | -15.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.